Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

SF 86-327 hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

96 API Suppliers, 27 USDMF, 25 CEP/COS, 17 JDMF, 12 EU WC, 37 KDMF, 23 NDC API, 25 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

118 FDF Dossiers, 25 FDA Orange Book, 39 Europe, 13 Canada, 16 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, SOLUTION;TOPICAL - 1%, GRANULE;ORAL - EQ 125MG BASE/PACKET, GRANULE;ORAL - EQ 187.5MG BASE/PACKET

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 Seqens, 4 DKSH, 4 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 21 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 2 Esteem Industries, 3 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 10 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

38 Coating Systems & Additives, 24 Topical, 23 Disintegrants & Superdisintegrants, 23 Fillers, Diluents & Binders, 22 Thickeners and Stabilizers, 20 Controlled & Modified Release, 17 Solubilizers, 15 Granulation, 14 Lubricants & Glidants, 12 Direct Compression, 12 Emulsifying Agents, 7 Co-Processed Excipients, 6 Taste Masking, 6 Film Formers & Plasticizers, 5 Surfactant & Foaming Agents, 5 Rheology Modifiers, 5 Parenteral, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Chewable & Orodispersible Aids, 2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 2 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 16 Regulatory FDF Prices

MARKET PLACE

17 APIs

17 APIs

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Dr. Reddy\'s Laboratories	India	Seongwoo Chemical Co., Ltd.	20050831-49-A-99-09(5)	Terbinafine hydrochloride	2014-07-07	Dr.Reddy's Laboratories Ltd	India	Unit-III, Plot No. 116, Sri Venkateswara Co-operative Industrial Estate, IDA Bollaram, Jinnaram Mandal, Sangareddy District, Telangana, India
29/11/2025	Dr. Reddy\'s Laboratories	India	Hwail Pharmaceutical Co., Ltd.	20050831-49-A-99-09(1)	Terbinafine hydrochloride	2011-06-15	Dr.Reddy's Laboratories Ltd.	India	Unit-III, Plot No. 116, Sri Venkateswara Co-operative Industrial Estate, IDA Bollaram, Jinnaram Mandal, Sangareddy District, Telangana, India

SF 86-327 Hydrochloride

SF 86-327 hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

96 API Suppliers

27 USDMF

25 CEP/COS

17 JDMF

12 EU WC

37 KDMF

23 NDC API

25 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

118 FDF Dossiers

25 FDA Orange Book

39 Europe

13 Canada

16 South Africa

25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 1%

SOLUTION;TOPICAL - 1%

GRANULE;ORAL - EQ 125MG BASE/PACKET

GRANULE;ORAL - EQ 187.5MG BASE/PACKET

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 Seqens

4 DKSH

4 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

1 ACG Worldwide

4 Actylis

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

21 BASF

10 Corel Pharma Chem

4 DFE Pharma

2 Esteem Industries

3 Finar

8 Gangwal Chemicals

4 Ideal Cures

2 Ingredion Pharma Solutions

10 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

9 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

3 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

10 Roquette

8 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

4 Silverline Chemicals

2 The Dow Chemical Company

1 Valens Pharmachem

4 Vasa Pharmachem

1 Vertellus

EXCIPIENTS BY APPLICATIONS

38 Coating Systems & Additives

24 Topical

23 Disintegrants & Superdisintegrants

23 Fillers, Diluents & Binders

22 Thickeners and Stabilizers

20 Controlled & Modified Release

17 Solubilizers

TABLET;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons